Skip to main content
. 2017 Dec 11;5(4):E830–E833. doi: 10.9778/cmajo.20170077

Table 2: Results of validation analysis using the outcome of original manual review of the electronic medical record charts as the reference standard.

Disease No. of cases Sensitivity (95% CI), % Specificity (95% CI), % Positive predictive value (95% CI), % Negative predictive value (95% CI), %
Chart +, CPCSSN + Chart -, CPCSSN + Chart -, CPCSSN - Chart +, CPCSSN -
Hypertension 915 66 885 40 95.8
(94.5-97.1)
93.1
(91.4-94.7)
93.3
(91.7-94.8)
95.7
(94.4-97.0)
Diabetes 311 33 1553 9 97.2
(95.4-99.0)
97.9
(97.2-98.6)
90.4
(87.3-93.5)
99.4
(99.0-99.8)
Depression 299 47 1473 87 77.5
(73.3-81.6)
96.9
(96.0-97.9)
86.4
(82.8-90.0)
94.4
(93.3-95.6)
Chronic obstructive pulmonary disease 125 25 1730 26 82.8
(76.8-88.8)
98.6
(98.0-99.1)
83.3
(77.4-89.3)
98.5
(98.0-99.1)
Dementia 82 15 1797 12 87.2
(80.5-94.0)
99.2
(98.8-99.6)
84.5
(77.3-91.7)
99.3
(99.0-99.7)
Osteoarthritis 507 88 1211 100 83.5
(80.6-86.5)
93.2
(91.9-94.6)
85.2
(82.4-88.1)
92.4
(90.9-93.8)
Epilepsy 130 19 1751 6 95.6
(92.1-99.0)
98.9
(98.4-99.4)
87.2
(81.9-92.6)
99.7
(99.4-99.9)
Parkinsonism 66 11 1812 17 79.5
(70.8-88.2)
99.4
(99.0-99.8)
85.7
(77.9-93.5)
99.1
(98.6-99.5)

Note: CI = confidence interval, CPCSSN = Canadian Primary Care Sentinel Surveillance Network.